Prosight Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$6.8M Buy
2022
Q2
Sell
2022
Q1
$3.71M Sell
2021
Q4
$5.41M Buy